Ardent Health Faces $90 Million Class Action Lawsuit Following Q3 2025 Disclosures
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 10h ago
0mins
Source: PRnewswire
- Lawsuit Initiation: Ardent Health, Inc. is facing a class action lawsuit due to significant accounting adjustments totaling approximately $90 million disclosed in Q3 2025, which caused the stock to plummet over 33% in mid-November.
- Investor Losses: The lawsuit seeks to represent investors who purchased Ardent securities between July 18, 2024, and November 12, 2025, highlighting serious deficiencies in the company's internal controls related to revenue recognition and liability reserves.
- Accounting Transparency Issues: The complaint alleges that Ardent failed to timely write off uncollectible accounts stemming from claim denials by third-party payors or uninsured patients, inflating accounts receivable and undermining investor confidence.
- Swift Market Reaction: Following the November 12, 2025 disclosure of a $42.6 million revenue decrease and a $47.2 million increase in operating expenses, the market reacted quickly, with Ardent's stock dropping $4.75 the next day, reflecting investor concerns about the company's financial health.
Analyst Views on ARDT
Wall Street analysts forecast ARDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDT is 13.96 USD with a low forecast of 10.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 9.210
Low
10.00
Averages
13.96
High
17.00
Current: 9.210
Low
10.00
Averages
13.96
High
17.00
About ARDT
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
